2 results match your criteria: "Bakoulev's National Medical Research Centre for Cardiac Surgery[Affiliation]"
The combination of Euroscore II with a new variable "Nongraftable coronary artery lesions" improves the discriminating power of the test in surgical patients with postinfarction ventricular septal defect and ventricular aneurysm.
J Card Surg
December 2022
Department of Surgical Treatment of Ischemic Heart Disease, Bakoulev's National Medical Research Centre for Cardiac Surgery, Moscow, Russia.
Background: We aimed to establish whether Euroscore II can be used for the prediction of hospital mortality in surgical patients with postinfarction intraventricular septal defect (PIVSD) and ventricular aneurysm (VA), and coexisting coronary artery lesions (CALs), and identify perioperative mortality risk factors to improve the discriminating power of Euroscore II.
Methods: This was a retrospective observational study. The inclusion criterion was PIVSD.
Complete anatomic surgical myocardial revascularisation during postinfarction ventricular septal defect and ventricular aneurysm repair is associated with improved short- and long-term outcomes.
J Card Surg
September 2022
Department of Surgical Treatment of Ischemic Heart Disease, Bakoulev's National Medical Research Centre for Cardiac Surgery, Moscow, Russia.
Background: Coronary artery bypass grafting (CABG) is recommended during acute postinfarction ventricular septal defect (PIVSD) repair, but clinical benefits of surgical revascularization in patients with subacute PIVSD have not been established. We aimed to evaluate the association of primary complete anatomic surgical myocardial revascularization (CASMR) during PIVSD and ventricular aneurysm (VA) repair on patients' short- and long-term outcomes.
Methods: This was a retrospective observational study.